Viking Therapeutics VKTX
NASDAQ VKTX
$36.75 -4.90 (-11.76%)
At close: Sep 24, 2026 · 4:00 PM EDT

Viking Therapeutics (VKTX) Accounts Payables (2014 - 2026)

Viking Therapeutics' (VKTX) quarterly Accounts Payables came in at $69.0 million in Q2 2026, up 1156.13% year-over-year from $5.5 million in Q2 2025, and up 2.72% quarter-over-quarter from $67.2 million in Q1 2026.

Analysis

Viking Therapeutics (VKTX) Accounts Payables (2014 - 2026) Analysis & Trends

Viking Therapeutics has disclosed Accounts Payables across 13 years of filings, most recently posting $69.0 million for Q2 2026.

  • In Q2 2026, Accounts Payables rose 1156.13% year-over-year to $69.0 million; the TTM figure through Jun 2026 stood at $69.0 million (up 1156.13% YoY), while the FY2025 annual figure was $53.3 million, up 442.66% from the prior year.
  • Accounts Payables came in at $69.0 million for Q2 2026 at Viking Therapeutics, up from $67.2 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $69.0 million in Q2 2026 to a low of $254000.0 in Q3 2024.
  • Average Accounts Payables over 5 years is $15.4 million, with a median of $5.9 million recorded in 2022.
  • Year-over-year, Accounts Payables tumbled 95.55% in 2024 and soared 1637.4% in 2025.
  • Over 5 years, Accounts Payables stood at $8.5 million in 2022, then slipped by 11.92% to $7.5 million in 2023, then soared by 30.63% to $9.8 million in 2024, then soared by 442.66% to $53.3 million in 2025, then grew by 29.6% to $69.0 million in 2026.
  • Per Business Quant data, the three most recent Accounts Payables figures were $69.0 million in Q2 2026, $67.2 million in Q1 2026, and $53.3 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 9.22 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 33.30 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn -22.89 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn 674.00 Mn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 429.50 Mn
10 Viking Therapeutics 4.86 Bn 4.86 Bn - 69.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 69.01 Mn
Mar 31, 2026 67.18 Mn
Dec 31, 2025 53.25 Mn
Sep 30, 2025 4.41 Mn
Jun 30, 2025 5.49 Mn
Mar 31, 2025 7.70 Mn
Dec 31, 2024 9.81 Mn
Sep 30, 2024 254,000.00
Jun 30, 2024 11.09 Mn
Mar 31, 2024 5.23 Mn
Dec 31, 2023 7.51 Mn
Sep 30, 2023 5.71 Mn
Jun 30, 2023 5.61 Mn
Mar 31, 2023 3.80 Mn
Dec 31, 2022 8.53 Mn
Sep 30, 2022 3.14 Mn
Jun 30, 2022 6.10 Mn
Mar 31, 2022 3.12 Mn
Dec 31, 2021 1.44 Mn
Sep 30, 2021 2.85 Mn
API Access

Viking Therapeutics Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=VKTX&period=max&api_key=YOUR_API_KEY